Close Menu

At his blog, Juniorprof wonders if new investigators without R01s are essentially out of luck when it comes to receiving stimulus funding. Capital improvement grants, he says, are targeted to those already with a large grant, while the challenge grants pose the problem of experience. "I can see the critique now: 'an excellent application but the lack of experience of the investigator raises the question of whether gains can be expected within 2 years,'" he writes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.